VIRGINIA RETIREMENT SYSTEMS ET Al Reduces Stake in HCA Healthcare, Inc. $HCA

VIRGINIA RETIREMENT SYSTEMS ET Al reduced its stake in HCA Healthcare, Inc. (NYSE:HCA) by 2.9% in the 4th quarter, Holdings Channel reports. The institutional investor owned 288,820 shares of the company’s stock after selling 8,480 shares during the period. HCA Healthcare accounts for approximately 0.8% of VIRGINIA RETIREMENT SYSTEMS ET Al’s investment portfolio, making the stock its 17th largest position. VIRGINIA RETIREMENT SYSTEMS ET Al’s holdings in HCA Healthcare were worth $134,839,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also modified their holdings of the business. Capital World Investors grew its holdings in shares of HCA Healthcare by 3.8% during the 3rd quarter. Capital World Investors now owns 4,959,336 shares of the company’s stock worth $2,113,662,000 after purchasing an additional 179,443 shares during the period. Arrowstreet Capital Limited Partnership grew its holdings in shares of HCA Healthcare by 1.8% during the 3rd quarter. Arrowstreet Capital Limited Partnership now owns 2,065,225 shares of the company’s stock worth $880,199,000 after purchasing an additional 36,414 shares during the period. Viking Global Investors LP grew its holdings in shares of HCA Healthcare by 58.5% during the 2nd quarter. Viking Global Investors LP now owns 1,872,133 shares of the company’s stock worth $717,214,000 after purchasing an additional 690,773 shares during the period. Legal & General Group Plc grew its holdings in shares of HCA Healthcare by 0.8% during the 3rd quarter. Legal & General Group Plc now owns 1,124,511 shares of the company’s stock worth $479,267,000 after purchasing an additional 8,478 shares during the period. Finally, Invesco Ltd. lifted its stake in HCA Healthcare by 1.1% during the 3rd quarter. Invesco Ltd. now owns 1,100,929 shares of the company’s stock worth $469,216,000 after acquiring an additional 11,829 shares in the last quarter. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, EVP Michael R. Mcalevey sold 1,694 shares of HCA Healthcare stock in a transaction that occurred on Wednesday, February 18th. The stock was sold at an average price of $533.37, for a total value of $903,528.78. Following the transaction, the executive vice president directly owned 8,853 shares in the company, valued at approximately $4,721,924.61. This trade represents a 16.06% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Company insiders own 1.50% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on HCA shares. Robert W. Baird decreased their target price on HCA Healthcare from $450.00 to $442.00 and set a “neutral” rating on the stock in a research note on Wednesday, April 15th. Oppenheimer decreased their target price on HCA Healthcare from $540.00 to $520.00 and set an “outperform” rating on the stock in a research note on Monday, April 27th. Wall Street Zen lowered HCA Healthcare from a “buy” rating to a “hold” rating in a research note on Saturday, May 2nd. JPMorgan Chase & Co. increased their target price on HCA Healthcare from $420.00 to $535.00 and gave the stock a “neutral” rating in a research note on Friday, February 20th. Finally, Mizuho increased their price target on HCA Healthcare from $540.00 to $585.00 and gave the company an “outperform” rating in a research report on Wednesday, February 25th. Sixteen research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, HCA Healthcare presently has a consensus rating of “Moderate Buy” and an average target price of $517.82.

HCA Healthcare Trading Up 0.9%

Shares of HCA opened at $430.11 on Wednesday. The company’s 50 day simple moving average is $485.46 and its 200-day simple moving average is $486.47. HCA Healthcare, Inc. has a 12-month low of $330.00 and a 12-month high of $556.52. The firm has a market cap of $95.42 billion, a PE ratio of 14.79, a price-to-earnings-growth ratio of 1.35 and a beta of 1.18.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings results on Friday, April 24th. The company reported $7.15 EPS for the quarter, missing the consensus estimate of $7.19 by ($0.04). HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The business had revenue of $19.11 billion during the quarter, compared to analysts’ expectations of $19.09 billion. During the same quarter last year, the company earned $6.45 EPS. The firm’s revenue for the quarter was up 4.3% compared to the same quarter last year. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, equities research analysts forecast that HCA Healthcare, Inc. will post 30.07 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, June 30th. Shareholders of record on Tuesday, June 16th will be paid a $0.78 dividend. This represents a $3.12 annualized dividend and a dividend yield of 0.7%. The ex-dividend date is Tuesday, June 16th. HCA Healthcare’s dividend payout ratio (DPR) is 10.73%.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.